Retatrutide stall timeline Retatrutide is the newest entrant, a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
A whey and collagen blend is worth considering for those who want to go beyond muscle support
It is important to note that phentermine topiramate is not licensed for use in the United Kingdom or the European Union
The recommended baseline panel for menopausal women considering weight loss peptides includes: fasting glucose and HbA1c (metabolic baseline), fasting insulin (insulin resistance assessment), lipid panel including triglycerides (cardiovascular risk), complete metabolic panel (liver and kidney function), IGF-1 (baseline for GH secretagogue monitoring), thyroid panel including TSH and free T4, estradiol and FSH (menopausal status confirmation), and DEXA scan if available (body composition baseline)
It is particularly good for central sensitisation